Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02499835 |
|---|---|
| Brief Title: | Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer |
| First Submitted : | July 14, 2015 |
| First Submitted that Met QC Criteria : | July 14, 2015 |
| First Posted : | July 16, 2015 (Estimate) |
| Results First Submitted : | July 25, 2022 |
| Results First Submitted that Met QC Criteria : | November 8, 2022 |
| Results First Posted : | December 1, 2022 |
| Last Update Submitted that Met QC Criteria : | November 8, 2022 |
| Last Update Posted : | December 1, 2022 |